Reliance Pharma Fund(G)

149.79 -0.09 (-0.06%) NAV as on 25-Mar-19
52-Week High ( ) 165.89 (07-Sep-18)
52-Week Low ( ) 132.39 (05-Jun-18)
Type Open ended scheme
Launch Date 05-Jun-04
Net Assets ( Cr ) 2663.71
Max Entry Load (%) 0.00
Max Exit Load (%) 0.00
Minimum Investment ( ) 5000

PERFORMANCE

Returns 6M (%) 1Y (%) 3Y (%) Since INC.
Scheme Return-7.5413.433.9820.05
Category Avg0.85-6.02-5.0710.70
Category Best6.111.76-0.8320.87
Category Worst-4.12-13.46-7.57-6.29
SENSEX3.1615.9914.27-
BSE HC-8.547.69-2.97-
NIFTY2.5913.5613.74-

Performance GRAPH

More from Perfomance »

Portfolio Summary

Name of Holding Instrument Hold (%)
Sun Pharmaceutical Industries LimitedDomestic Equities11.2
Divi's Laboratories LimitedDomestic Equities11.18
Aurobindo Pharma LimitedDomestic Equities9.36
Cipla LimitedDomestic Equities9.27
Dr. Reddy's Laboratories LimitedDomestic Equities7.41
More from Portfolio Summary »

INvestment Pattern Details

Type Minimum Maximum
Equity and Equity related Instruments of companies in Pharma Sector80100
Debt & MMI020
Units issued by REITs and InvITs010
More from Investment Pattern Details »

Return Calculator

MARKET STATS As on 25/03/2019 As on 25/03/2019

11354.25 (-0.90) 37808.91 (-0.93)

TOP GAINERS

Company Price Change Gain (%)
MPS Infotecnics0.100.05100.00
FCS Software Soltns.0.250.0525.00

TOP LOSERS

Company Price Change Loss (%)
ATN International0.05-0.05-50.00
MVL0.20-0.05-20.00

Portfolio Comparison

MUTUAL FUND ACTIVITY